CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 602 enrolled
Drug / intervention
1% Clindamycin/5% Benzoyl Peroxide Topical Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01044264
NCT01044264N/ACompleted
CompareCT.gov

A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled Study Comparing Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations in the Treatment of Moderate to Severe Acne Vulgaris

Padagis LLC·interventional·Posted Jan 7, 2010·Updated Jul 12, 2023

In Brief

A clinical study evaluating 1% Clindamycin/5% Benzoyl Peroxide Topical Gel and Placebo for Acne Vulgaris. Completed, enrolled 602 participants.

Detailed Summary

A randomized, double-blind, multiple-site, placebo-controlled, parallel-group clinical study conducted to evaluate the bioequivalence of two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel formulations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 7, 2010
Enrollment StartDec 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.5 years ago

Interventions

1% Clindamycin/5% Benzoyl Peroxide Topical Geldrug

Topical Gel

Placebodrug

Placebo